前臨床イメージング（イン・ビボ）の世界市場：光学イメージング、PET、SPECT、CT、MRI、超音波、光音響イメージング、磁気粒子画像法、光学イメージング試薬、コントラスト剤、PETトレーサー、SPECTプローブ...市場調査レポートについてご紹介

1 Introduction (Page No. – 16)
1.1 Objectives of the Study
1.2 Preclinical Imaging Market Definition
1.3 Preclinical Imaging Market Scope
1.3.1 Markets Covered
1.3.1.1 Preclinical Imaging Market Segmentation
1.3.1.2 Preclinical Imaging Systems Market Segmentation
1.3.1.3 Preclinical Imaging Reagents Market Segmentation
1.3.2 Geographic Scope
1.3.3 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology (Page No. – 21)
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Breakdown of Primaries
2.2 Preclinical Imaging Market Size Estimation
2.2.1.1 Bottom-Up Approach
2.2.1.2 Top-Down Approach
2.3 Preclinical Imaging Market Breakdown and Data Triangulation
2.4 Research Assumptions & Limitations
2.4.1 Assumptions

3 Executive Summary (Page No. – 30)
3.1 Introduction
3.2 Current Scenario
3.3 Future Outlook
3.4 Conclusion

4 Premium Insights (Page No. – 34)
4.1 Global Preclinical Imaging Market Overview
4.2 Preclinical Imaging Products Market Share, By Region (2016)
4.3 Global Preclinical Imaging Systems Market, By Modality (2016–2021)
4.4 Global Preclinical Imaging Reagents Market, By Type (2016–2021)
4.5 Preclinical Imaging Market, By Region (2016 vs 2021)

5 Preclinical Imaging Market Overview (Page No. – 39)
5.1 Introduction
5.2 Preclinical Imaging Market Dynamics
5.2.1 Key Market Drivers
5.2.1.1 Technological Advancements in the Field of Molecular Imaging
5.2.1.2 Increasing Market Demand for Noninvasive Small-Animal Imaging Techniques
5.2.1.3 Growing Number of Public-Private Initiatives and Funding to Support Preclinical Researches
5.2.2 Key Market Restraints
5.2.2.1 Strict Regulations Governing Preclinical Research
5.2.2.2 Significant Installation and Operational Costs Associated With Preclinical Imaging Modalities
5.2.3 Key Market Opportunity
5.2.3.1 Emerging Markets to Offer New Growth Opportunities
5.2.4 Key Market Challenge
5.2.4.1 Technological and Procedural Limitations Associated With Standalone Preclinical Imaging Systems

6 Industry Insights (Page No. – 46)
6.1 Introduction
6.2 Value Chain Analysis
6.3 Supply Chain Analysis
6.3.1 Key Stakeholders
6.3.2 Key Influencers
6.4 Industry Trends
6.4.1 Ongoing Development of Hybrid and Multi-Modality Preclinical Imaging Systems
6.5 Porter’s Five Forces Analysis
6.5.1 Threat of New Entrants
6.5.2 Threat of Substitutes
6.5.3 Bargaining Power of Suppliers
6.5.4 Bargaining Power of Buyers
6.5.5 Intensity of Competitive Rivalry

7 Global Preclinical Imaging Market, By Modality (Page No. – 54)
7.1 Introduction
7.2 Optical Imaging Systems
7.2.1 Bioluminescence/Fluorescence Imaging Systems
7.2.2 Standalone Fluorescence Imaging Systems
7.2.3 (Optical + X-Ray)/(Optical + CT) Systems
7.3 Nuclear Imaging Systems
7.3.1 Micro-PET Systems
7.3.1.1 Standalone PET Systems
7.3.1.2 PET/CT Systems
7.3.1.3 PET/MRI Systems
7.3.2 Micro-Spect Systems
7.3.2.1 Standalone Spect Systems
7.3.2.2 Spect/CT Systems
7.3.2.3 Spect/MRI Systems
7.3.3 Trimodality (Spect/PET/CT) Systems
7.4 Micro-MRI
7.5 Micro-Ultrasound
7.6 Micro-CT
7.7 Photoacoustic Imaging Systems
7.8 Magnetic Particle Imaging (MPI) Systems

8 Global Preclinical Imaging Market, By Reagent (Page No. – 73)
8.1 Introduction
8.2 Preclinical Optical Imaging Reagents
8.2.1 Bioluminescent Imaging Reagents
8.2.1.1 Luciferins
8.2.1.2 Proluciferins
8.2.1.3 Coelenterazine
8.2.1.4 Other Bioluminescent Imaging Reagents
8.2.2 Fluorescent Imaging Reagents
8.2.2.1 Green Fluorescent Proteins
8.2.2.2 Red Fluorescent Proteins
8.2.2.3 Infrared Dyes
8.2.2.4 Other Fluorescent Imaging Reagents
8.3 Preclinical Nuclear Imaging Reagents
8.3.1 Preclinical PET Tracers
8.3.1.1 Fluorine-18-Based Preclinical PET Tracers
8.3.1.2 Carbon-11-Based Preclinical PET Tracers
8.3.1.3 Copper-64-Based Preclinical PET Tracers
8.3.1.4 Other PET Tracers
8.3.2 Preclinical Spect Probes
8.3.2.1 Technetium-99m-Based Preclinical Spect Probes
8.3.2.2 Iodine-131-Based Preclinical Spect Probes
8.3.2.3 Gallium-67-Based Preclinical Spect Probes
8.3.2.4 Thallium-201-Based Preclinical Spect Probes
8.3.2.5 Other Spect Probes
8.4 Preclinical MRI Contrast Agents
8.4.1 Gadolinium-Based Preclinical Contrast Agents
8.4.2 Iron-Based Preclinical Contrast Agents
8.4.3 Manganese-Based Preclinical Contrast Agents
8.5 Preclinical Ultrasound Contrast Agents
8.6 Preclinical CT Contrast Agents
8.6.1 Iodine-Based Preclinical CT Contrast Agents
8.6.2 Barium-Based Preclinical CT Contrast Agents
8.6.3 Gold Nanoparticles
8.6.4 Gastrografin-Based Preclinical CT Contrast Agents

9 Preclinical Imaging Market, By Region (Page No. – 105)
9.1 Introduction
9.2 North America
9.3 Europe
9.4 Asia-Pacific
9.5 Rest of the World (RoW)

10 Competitive Landscape (Page No. – 120)
10.1 Overview
10.2 Preclinical Imaging Market Share Analysis, By Key Player, 2015
10.3 Competitive Scenario
10.3.1 New Product Launches
10.3.2 Agreements, Partnerships, and Collaborations
10.3.3 Geographical Expansions
10.3.4 Acquisitions

11 Company Profiles (Page No. – 127)
11.1 Introduction
11.1.1 Geographic Benchmarking
11.2 Perkinelmer, Inc.
11.2.1 Business Overview
11.2.2 Products Offered
11.2.3 Recent Developments (2013-2016)
11.2.4 MnM View
11.3 Bruker Corporation
11.3.1 Business Overview
11.3.2 Products Offered
11.3.3 Recent Developments (2013-2016)
11.3.4 MnM View
11.4 Fujifilm Holdings Corporation
11.4.1 Business Overview
11.4.2 Products Offered
11.4.3 Recent Developments (2013-2016)
11.4.4 MnM View
11.5 Mediso Ltd.
11.5.1 Business Overview
11.5.2 Products Offered
11.5.3 Recent Developments (2013-2016)
11.6 Milabs B.V.
11.6.1 Business Overview
11.6.2 Products Offered
11.6.3 Recent Developments (2013-2016)
11.7 MR Solutions Ltd.
11.7.1 Business Overview
11.7.2 Products Offered
11.7.3 Recent Developments (2013-2016)
11.8 Aspect Imaging Ltd.
11.8.1 Business Overview
11.8.2 Products Offered
11.8.3 Recent Developments (2013-2016)
11.9 Li-Cor Biosciences
11.9.1 Business Overview
11.9.2 Products Offered
11.9.3 Recent Developments (2013-2016)
11.10 Trifoil Imaging
11.10.1 Business Overview
11.10.2 Products Offered
11.10.3 Recent Developments (2013-2016)
11.11 Miltenyi Biotec GmbH
11.11.1 Business Overview
11.11.2 Products Offered
11.11.3 Recent Developments (2013-2016)

12 Appendix (Page No. – 152)
12.1 Insights of Industry Experts
12.2 Discussion Guide
12.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
12.4 Introducing RT: Real-Time Market Intelligence
12.5 Available Customizations
12.6 Related Reports